According to our findings and those in the literature, CD146 can be considered as a membrane antigen suitable for identification and enrichment in melanoma liquid biopsies, as a highly effective molecular “warning marker for melanoma minimal residual disease monitoring“ [142], and finally as a soluble protein index of inflammation and putative response to therapeutic treatments. The gene discussed is MCAM; the disease is melanoma.